What Happened?
34994, FL-based Stuart-Therapeutics Appointed Eric Schlumpf as President and Chief Executive Officer
About the Company
Stuart Therapeutics was established in 2017 for the development and commercialization of PolyCol, a versatile therapeutic platform that offers a unique tissue reparative approach to a variety of ophthalmic disease indications.
About the Person
Eric Schlumpf is President and Chief Executive Officer at Stuart Therapeutics. Previously, Eric held various senior HR leadership roles in the industry.
Info Source
News
Short Profile